Role of Bioelectrical Impedance Analysis in the Evaluation of Patients with Upper Limb Lymphedema

Lymphat Res Biol. 2020 Dec;18(6):555-559. doi: 10.1089/lrb.2019.0085. Epub 2020 Mar 25.

Abstract

Background: Monofrequency bioelectrical impedance analysis (BIA) protocols seek to further quantify changes in lymphedema compared with traditional circumferential evaluations. Complex decongestive therapy (CDT) is an effective method of reducing unilateral upper limb lymphedema secondary to breast cancer treatments. Comparing lymphedema measurements between segmental tetrapolar BIA, total body BIA, and circumferential measurements during therapeutic changes can improve our quantitative assessment ability for this prevalent medical complication. Methods and Results: Twenty-two patients with breast-cancer-related unilateral upper limb lymphedema participated in this prospective observational study. Circumferential measurements, segmental tetrapolar BIA, and total body BIA were obtained and compared before CDT, immediately after 10 sessions of CDT, and 30 days post-CDT to assess lymphedema. The segmental tetrapolar BIA correlated well with improvements in circumferential measurements of the limb. We found that the resistance value cutoff point of 237 Ω could indicate a recurrence of lymphedema. Conclusions: Segmental, tetrapolar monofrequency BIA provides a simple method to monitor and evaluate the efficacy of therapy in the outpatient setting by operators with minimal training. This protocol could aid quantitative evaluations of unilateral upper limb lymphedema.

Keywords: BIA; CDT; bioelectrical impedance; breast cancer-related lymphedema; upper extremity lymphedema.

Publication types

  • Observational Study

MeSH terms

  • Breast Cancer Lymphedema* / diagnosis
  • Breast Neoplasms* / complications
  • Electric Impedance*
  • Female
  • Humans
  • Prospective Studies
  • Upper Extremity